𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pegylated interferons: chemical and clinical differences

✍ Scribed by G. R. Foster

Book ID
108603788
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
67 KB
Volume
20
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Merimepodib, pegylated interferon, and r
Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders
✍ Vinod K. Rustgi; William M. Lee; Eric Lawitz; Stuart C. Gordon; Nezam Afdhal; Fr πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 240 KB πŸ‘ 1 views

on behalf of the MErimepodib TRiple cOmbination (METRO) study group Merimepodib (MMPD) is an orally administered, inosine monophosphate dehydrogenase inhibitor that has shown antiviral activity in nonresponders with chronic hepatitis C (CHC) when combined with pegylated interferon alfa 2a (Peg-IFN-a

Clinical uses of interferons
Clinical uses of interferons
✍ Robert M. Friedman πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 415 KB
The Clinical Use of Interferons
The Clinical Use of Interferons
✍ Q. Scott Ringenberg; Philip C. Anderson πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 77 KB
Clinical and histological efficacy of pe
Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation
✍ Inmaculada FernΓ‘ndez; Juan Carlos Meneu; Francisco Colina; Ignacio GarcΓ­a; Raque πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 143 KB πŸ‘ 2 views

Treatment of recurrent hepatitis C in liver transplant is controversial. The aim of our study was to evaluate the clinical and histological efficacy of pegylated interferon alpha 2b (PEG-IFN) and ribavirin therapy of recurrent hepatitis C after liver transplantation (LT). We prospectively included 4

Pegylated interferon and ribavirin in re
Pegylated interferon and ribavirin in real life: Efficacy versus effectiveness
✍ Γ‚ngelo Zambam de Mattos; Paulo Roberto Lerias de Almeida; Cristiane Valle Tovo; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 411 KB

We read with great interest the practice guidelines for the diagnosis and management of autoimmune hepatitis recently issued by the American Association for the Study of Liver Diseases (AASLD). 1 In particular, we appreciate the new definition of biochemical remission, which now requires not only no